Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
2006 | 1 |
2013 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
Growth Horm IGF Res. 2006 Jul;16 Suppl A:S55-61. doi: 10.1016/j.ghir.2006.03.001. Epub 2006 Apr 18.
Growth Horm IGF Res. 2006.
PMID: 16624605
Review.
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whereas the insulin-like growth factor I (IGF-I) potentiates insulin-like actions. ...Growth h …
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whe …
Effect of recombinant insulin-like growth factor-1 treatment on short-term linear growth in a child with Majewski osteodysplastic primordial dwarfism type II and hepatic insufficiency.
Faienza MF, Acquafredda A, D'Aniello M, Soldano L, Marzano F, Ventura A, Cavallo L.
Faienza MF, et al.
J Pediatr Endocrinol Metab. 2013;26(7-8):771-4. doi: 10.1515/jpem-2012-0397.
J Pediatr Endocrinol Metab. 2013.
PMID: 23612698
In consideration of the low levels of insulin-like growth factor-1 (IGF-1) as well as of hepatic insufficiency, we started the treatment with recombinant human IGF-1 (rhIGF-1) at the dose of 0.04 mg/kg in 2 doses/day, with a …
In consideration of the low levels of insulin-like growth factor-1 (IGF-1) as well as of hepatic i …
Item in Clipboard
Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short children.
Eshet R, Klinger B, Silbergeld A, Laron Z.
Eshet R, et al.
Clin Endocrinol (Oxf). 1993 Dec;39(6):687-93. doi: 10.1111/j.1365-2265.1993.tb02428.x.
Clin Endocrinol (Oxf). 1993.
PMID: 8287588
OBJECTIVE: To study the in-vivo regulation of IGF-I binding sites on erythrocytes (RBC) following administration of growth hormone (hGH) to constitutionally short children. Recently, owing to biosynthetic techniques, treatment with hGH has been administered not only to chi …
OBJECTIVE: To study the in-vivo regulation of IGF-I binding sites on erythrocytes (RBC) following administration of growth hormone (h …
Item in Clipboard
Cite
Cite